These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
772 related articles for article (PubMed ID: 21546202)
1. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Sader HS; Moet GJ; Farrell DJ; Jones RN Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202 [TBL] [Abstract][Full Text] [Related]
2. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). Sader HS; Watters AA; Fritsche TR; Jones RN BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Sader HS; Jones RN Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China. Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009. Dowzicky MJ Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154 [TBL] [Abstract][Full Text] [Related]
6. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. Sader HS; Jones RN; Rossi KL; Rybak MJ J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India. Dhawan B; Gadepalli R; Kapil A Diagn Microbiol Infect Dis; 2009 Oct; 65(2):196-8. PubMed ID: 19748433 [TBL] [Abstract][Full Text] [Related]
8. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium. McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]
10. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program. Sader HS; Flamm RK; Farrell DJ; Jones RN Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003). Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2005 Dec; 53(4):329-32. PubMed ID: 16263233 [TBL] [Abstract][Full Text] [Related]
13. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M; Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid. Barber KE; Smith JR; Raut A; Rybak MJ J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277 [TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of daptomycin against VRE and MRSA strains]. Aktaş G; Derbentli S Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Sader HS; Streit JM; Fritsche TR; Jones RN Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey. Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140 [No Abstract] [Full Text] [Related]
18. [Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods]. Gómez-Garcés JL; López-Fabal F; Burillo A; Gil Y Rev Esp Quimioter; 2010 Jun; 23(2):87-92. PubMed ID: 20559607 [TBL] [Abstract][Full Text] [Related]
19. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725 [TBL] [Abstract][Full Text] [Related]
20. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007. Dowzicky MJ; Park CH Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]